Fexofenadine Hydrochloride

CAS 153439-40-8 17 current records 7 historicalSmall Molecule

Who holds supplier records for Fexofenadine Hydrochloride? 17 organisations hold a current record for Fexofenadine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (14), Germany (1) and Israel (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Fexofenadine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fexofenadine-hydrochloride

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    14 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Fexofenadine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India14Germany1Israel1Country not recorded for 1
Need Fexofenadine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Fexofenadine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO DRUGS LIMITED HyderabadIN
CEP 2012-278 - Rev 05
Fexofenadine hydrochloride
Oct 2026—
VIRUPAKSHA ORGANICS LIMITED HyderabadIN
CEP 2009-160 - Rev 05
Fexofenadine hydrochloride, Non-micronised and micronised
Apr 2026—
SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED HyderabadIN
CEP 2023-294 - Rev 00
Fexofenadine hydrochloride
Dec 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2025-159 - Rev 00
Fexofenadine hydrochloride, Form I (FXA4)
Jul 2025—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2015-256 - Rev 01
Fexofenadine hydrochloride
May 2025Inspected Mar 2026
Spain
SYNTHIMED LABS PRIVATE LIMITED DerabassiIN
CEP 2008-226 - Rev 03
Fexofenadine hydrochloride
Aug 2024Inspected Aug 2026
Slovenia
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2015-234 - Rev 02
Fexofenadine hydrochloride
Jun 2024—
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2022-134 - Rev 00
Fexofenadine hydrochloride
Dec 2023—
EUROAPI GERMANY GmbH Frankfurt am MainDE
R1-CEP 2009-297 - Rev 03
Fexofenadine hydrochloride
Dec 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (7)

Organisations whose Type II DMFs for Fexofenadine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 7 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Fexofenadine Hydrochloride is a non-sedating antihistamine used to treat allergic rhinitis and chronic urticaria. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Chemical identity

IUPAC name
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid;hydrochloride
Canonical SMILES
CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl
InChIKey
RRJFVPUCXDGFJB-UHFFFAOYSA-N
Synonyms
Allegra API, allegra, carboxyterfenadine hydrochloride, fexofenadine hcl, mdl 16,455a, mdl-16455a, telfast, terfenadine carboxylate hydrochloride

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Histamine-1 Receptor Antagonist
Mechanism of action
Histamine H1 Receptor Antagonists

Therapeutic areas

AllergyOtolaryngology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Fexofenadine Hydrochloride?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Fexofenadine Hydrochloride: Dr. Reddy's Laboratories Ltd. (India), Hetero Drugs Limited (India), MOREPEN LABORATORIES LTD (India), SYNTHIMED LABS PRIVATE LIMITED (India), VASUDHA PHARMA CHEM LTD (India), VIRUPAKSHA ORGANICS LTD (India), APITORIA PHARMA PRIVATE LTD (India) and CHEMECA DRUGS PRIVATE LTD (India), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Fexofenadine Hydrochloride Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 15757, 34645), Hetero Drugs Limited (DMF 25637), MOREPEN LABORATORIES LTD (DMF 30692), SYNTHIMED LABS PRIVATE LIMITED (DMF 24597), VASUDHA PHARMA CHEM LTD (DMF 29740), VIRUPAKSHA ORGANICS LTD (DMF 23070), APITORIA PHARMA PRIVATE LTD (DMF 28995) and CHEMECA DRUGS PRIVATE LTD (DMF 36554) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Fexofenadine Hydrochloride records mean?

7 organisations have only inactive Type II DMFs for Fexofenadine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Fexofenadine Hydrochloride have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Fexofenadine Hydrochloride on the EDQM register, including HETERO DRUGS LIMITED Hyderabad (IN), VIRUPAKSHA ORGANICS LIMITED Hyderabad (IN), SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), MOREPEN LABORATORIES LIMITED Baddi (IN) and SYNTHIMED LABS PRIVATE LIMITED Derabassi (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Fexofenadine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Fexofenadine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.